Alerts

Xigris (drotrecogin alfa) is being withdrawn from the market because it does not improve survival rates in severe sepsis patients. Stop using it and consult your doctor for alternative treatments.

We are advising that Movectro (cladribine) has been withdrawn from supply in Australia due to commercial reasons.

We are reviewing the safety of the Pneumovax 23 vaccine due to reports of severe local reactions and have updated our revaccination recommendations.

We are recalling Thelin (sitaxentan) worldwide due to serious liver risks. Consult your doctor if you have concerns.

Seasonal flu vaccine: Response to the West Australian (Stokes) Review